- All sections
- C - Chemistrymetallurgy
- C12N - Microorganisms or enzymescompositions thereofpropagating, preserving, or maintaining microorganismsmutation or genetic engineeringculture media
- C12N 15/79 - Vectors or expression systems specially adapted for eukaryotic hosts
Patent holdings for IPC class C12N 15/79
Total number of patents in this class: 1531
10-year publication summary
64
|
90
|
123
|
116
|
112
|
100
|
87
|
93
|
73
|
80
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
The Regents of the University of California | 20108 |
64 |
President and Fellows of Harvard College | 6002 |
29 |
Massachusetts Institute of Technology | 10115 |
27 |
Regeneron Pharmaceuticals, Inc. | 4355 |
25 |
The Trustees of the University of Pennsylvania | 4349 |
19 |
The Broad Institute, Inc. | 1842 |
18 |
The Board of Trustees of the Leland Stanford Junior University | 6476 |
17 |
Novartis AG | 10721 |
15 |
Corbion Biotech, Inc. | 136 |
13 |
The Johns Hopkins University | 5714 |
10 |
University of Massachusetts | 2232 |
10 |
Monsanto Technology LLC | 8290 |
9 |
Ramot at Tel-Aviv University Ltd. | 1486 |
9 |
Yale University | 2418 |
9 |
DSM IP Assets B.V. | 5572 |
8 |
The General Hospital Corporation | 4770 |
8 |
University of Florida Research Foundation, Inc. | 4053 |
8 |
The Brigham and Women's Hospital, Inc. | 2215 |
8 |
Children's Medical Center Corporation | 1887 |
8 |
Compass Therapeutics LLC | 46 |
8 |
Other owners | 1209 |